Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Collplant Holdings (CLGN)
NASDAQ:CLGN
RESEARCH TOOLSreports
Holding CLGN?
Track your performance easily
CLGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.10 - $6.99
Previous Close$4.77
Volume2.66K
Average Volume (3M)12.73K
Market Cap
$57.27M
Enterprise Value$30.82M
Total Cash (Recent Filing)$26.91M
Total Debt (Recent Filing)$3.16M
Price to Earnings (P/E)―
Beta0.02
Next Earnings
Nov 28, 2024EPS Estimate
-$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.52
Shares Outstanding11,452,672
10 Day Avg. Volume8,420
30 Day Avg. Volume12,731
Standard Deviation0.19
R-Squared0.00535
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.93
Price to Sales (P/S)5.07
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue176.14
Enterprise Value/Gross Profit3.44
Enterprise Value/Ebitda-3.80
Forecast
1Y Price Target
$12.50Price Target Upside150.01% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Collplant Holdings News
PremiumCompany Announcements
CollPlant Announces Upcoming Shareholder Meeting
PremiumCompany Announcements
CollPlant Pursues $3B Market with 3D-Printed Implants
PremiumCompany Announcements
CollPlant and Stratasys Pioneer Regenerative Breast Implants
Bulls Say, Bears Say
Bulls Say
Financial PerformanceCollPlant had approximately $23.2M in cash and cash equivalents, which is believed to be sufficient to fund operations.
Innovative TechnologyCollPlant initiated a second preclinical study of human collagen-based breast implants, which are manufactured using innovative 3D printing technology.
Milestone Payments And RoyaltiesCollPlant remains eligible to receive additional milestone payments of up to $26M and is expected to receive royalties on sales from AbbVie upon commercialization.
Bears Say
EarningsFor FY23, the company reported total revenues of $11M, compared to the consensus estimate of $13.6M, and a net loss of $0.62 per diluted share, compared to the consensus estimated net loss of $0.35 per share.
Financial PerformanceFor 1Q24, the company reported total revenues of approximately $0.10M, compared to the consensus estimate of $0.41M.
Financial PerformanceFor 1Q24, the company reported a net loss of $0.37 per diluted share, compared to the consensus estimated net loss of $0.39 per share.
---
Ownership Overview
0.00%
Insiders
0.05% Mutual Funds
11.42% Other Institutional Investors
88.53% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CLGN FAQ
What was Collplant Holdings’s price range in the past 12 months?
Collplant Holdings lowest stock price was $4.10 and its highest was $6.99 in the past 12 months.
What is Collplant Holdings’s market cap?
Currently, no data Available
When is Collplant Holdings’s upcoming earnings report date?
Collplant Holdings’s upcoming earnings report date is Nov 28, 2024 which is in 70 days.
How were Collplant Holdings’s earnings last quarter?
Collplant Holdings released its earnings results on Aug 20, 2024. The company reported -$0.37 earnings per share for the quarter, missing the consensus estimate of -$0.27 by -$0.1.
Is Collplant Holdings overvalued?
According to Wall Street analysts Collplant Holdings’s price is currently Undervalued.
Does Collplant Holdings pay dividends?
Collplant Holdings does not currently pay dividends.
What is Collplant Holdings’s EPS estimate?
Collplant Holdings’s EPS estimate is -$0.29.
How many shares outstanding does Collplant Holdings have?
Collplant Holdings has 11,454,512 shares outstanding.
What happened to Collplant Holdings’s price movement after its last earnings report?
Collplant Holdings reported an EPS of -$0.37 in its last earnings report, missing expectations of -$0.27. Following the earnings report the stock price went down -1.02%.
Which hedge fund is a major shareholder of Collplant Holdings?
Among the largest hedge funds holding Collplant Holdings’s share is ARK Investment Management LLC. It holds Collplant Holdings’s shares valued at N/A.
---
Collplant Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.50 (150.01% Upside)
$12.50 (150.01% Upside)
Hedge Fund Trend
Decreased
By 235.7K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.23%
12-Months-Change
Fundamentals
Return on Equity
-61.55%
Trailing 12-Months
Asset Growth
-36.09%
Trailing 12-Months
Company Description
Collplant Holdings
CollPlant Biotechnologies Ltd. is a regenerative medicine company. It engages in the research, development, manufacture and marketing of medical products for tissue repair, initially for orthobiologics and advanced wound care markets. The company's products include VergenixSTR, VergenixFG, CollPlant Surgical Matrix. Collplant Holdings was founded by in June 2004 and is headquartered in Ness-Ziona, Israel.
---
CLGN Earnings Call
Q2 2024
0:00 / 0:00
---
CLGN Stock 12 Month Forecast
Average Price Target
$12.50
▲(150.01% Upside)
Technical Analysis
Best Analysts Covering CLGN
1 Year
1 Year Success Rate
6/15 ratings generated profit
1 Year Average Return
+0.18%
initiated a buy rating 2 months ago
Copying Jason Kolbert's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of +0.18% per trade.
---